« Return to News | CROs/Service Providers

ScinoPharm, Sundia MediTech partner in China

Friday, August 9, 2013 12:59 PM

CROs ScinoPharm Changshu Pharmaceuticals and Sundia MediTech have collaborated to seek more opportunities for contract research and manufacturing services (CRAMS) in mainland China.

Dr. Jo Shen, chief executive officer of ScinoPharm Taiwan and chairman of ScinoPharm Changshu, said, “Resources from our Changshu site in Jiangsu province, China, and the Shanghai-based company Sundia will be combined to establish a robust collaboration with single-source solutions to address the increasing number of multinational companies shifting their drug development research and clinical trials in China.”

“Sundia has established long-standing and strong relationships with a number of big pharmaceuticals and small/medium-sized biotech companies from the U.S., Europe, Japan and South Korea in the fields of chemistry, biology, preclinical, formulation and API manufacture, helping our clients and partners to bring drugs to the market efficiently,” said Dr. Chen Chen, Sundia’s chief executive officer.

This alliance combines Sundia’s technical know-how and capabilities in new drug R&D with ScinoPharm’s process R&D and commercial production, especially in highly potent oncological APIs. Both companies will further support customer needs with integrated services such as drug development, research, clinical trials and commercial manufacturing.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.